Redfund Capital Corp. - Die Cannabis-Bank - 500 Beiträge pro Seite

[tzadoz2014]

Redfund Capital Corp.
https://www.redfundcapital.com/
WKN: A2N4AA
ISIN: CA75745T1084
CSE (unter Kürzel "LOAN" zu finden): https://web.tmxmoney.com/quote.php?qm_symbol=LOAN:CNX" target="_blank" rel="nofollow ugc noopener">https://web.tmxmoney.com/quote.php?qm_symbol=LOAN:CNX


Redfund kann man wohl am besten als eine Mischung aus Bank und Beteiligungsgesellschaft bezeichnen. Der Fokus liegt auf eher junge Unternehmen (noch nicht an der Börse gelistet) aus der Cannabis-Branche. Diese Unternehmen haben meist allerdings auch schon erste Erfolge zu verzeichnen.

Sie vergeben an diese Unternehmen Kredite/Darlehen, welche wandelbar in Aktien (bzw. in Anteile an der Firma) sind. Weshalb es für Redfund und ihren Aktionären besonders interessant wird, wenn eines dieser Unternehmen an die Börse geht. Womit aktuell diese Aktie auch eher etwas für spekulative Anleger ist.

Erste "clients" hat man bereits. https://www.redfundcapital.com/strategies/

Unternehmensbeschreibung laut Homepage

About Redfund Capital

Designed by bankers and entrepeneurs with years of experience in business, consulting, capital markets, corporate finance and healthcare services. Redfund Capital provides a debt financing facility to help companies build their valuation and get to the next level in their financing cycle without giving away equity prematurely in their growth cycle.

Our Mission

Redfund will incubate and accelerate revenue producing companies to expand more rapidly by providing them capital and services to get ahead of their curve. Our merchant bank is looking beyond borders and creating global companies with strong fundamentals ready to expand.

Our Clients

Our investments will be deployed to entities who have demonstrated success in their business but need a capital bridge to expand their companies. Each project is vetted by our team of professionals and analyzed from their financials and current business plans. Once approved, the collateral used to securitize their individual loans is scrutinized by our legal team.

[tzadoz2014]

Die letzten Unternehmensmeldungen:

https://www.redfundcapital.com/redfund-client-biominerales-p…
REDFUND CLIENT BIOMINERALES PHARMA COLOMBIA ANNOUNCES FIRST PURCHASE ORDER

https://www.redfundcapital.com/redfund-client-biolog-inc-pro…
REDFUND CLIENT BIOLOG INC. PROVIDES PROGRESS REPORT

https://www.redfundcapital.com/redfund-updates-on-biomineral…
REDFUND UPDATES ON BIOMINERALES PHARMA COLOMBIA OPERATIONS

[tzadoz2014]

News

Englisch: https://web.tmxmoney.com/article.php?newsid=5143324980488950…
https://www.wallstreet-online.de/nachricht/10914381-redfund-…

Vancouver, British Columbia / TheNewswire / October 9th 2018 - Redfund Capital Corp (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) (Redfund or the "Company") is pleased to announce its financing of RxMM Health Capital Inc.'s subsidiary RxMM Healthcare Inc. ("RxMM).

The Company

RxMM Health Capital Inc., ("RxMM") is a medical cannabis company incorporated in Vancouver, British Columbia. RxMM comprises of a group of six subsidiary companies that are involved in the cultivation, extraction and manufacturing of pharmaceutical grade cannabis for OTC medical and wellness products. The Company is planning to have over 4 million sq. of pharma-grade cannabis under cultivation by mid-2022.

RxMM's subsidiary RxMM Healthcare Inc. is in the process of launching Alzheimers Defense ("AD") which is a proprietary, CBD infused "all natural" nutraceutical product. AD's claims are underpinned by two scientific research studies, funded by the National Institutes of Health and conducted at the University of California, Irvine, Institute for Memory Impairments and Neurological Disorders (UCI MIND) and the University of Kentucky. Both these studies support the AD's efficacy claims. Currently, there is no other preventative Dementia/ Alzheimer product on the market with evidence to support product efficacy claims. ( www.rxmmhealthcare.com ; http://www.rxmmhealthcapital.com )

RxMM Healthcare products to be marketed consist of Alzheimer's Defense daily tablets, Alzheimer's Defense PLUS+ CBD daily gel caps, FDA approved NeuroNasal Strips and CBD PLUS+ anti-oxidant topical patches to support overall antioxidant and anti-inflammatory wellness for up to 72-hours.

The Investment

Redfund and RxMM signed a 2 year term convertible secured promissory note on October 5th 2018 for $500,000 at an annual interest rate of 14%, of which the first tranche is $200,000 and will be invested in RxMM's subsidiary RxMM Healthcare. The Note may be converted at Redfund's discretion at any time during the term and the Company has a right of first refusal to provide financing to RxMM upon the same business terms as are being offered to RxMM by any other funders. RxMM afforded Redfund stock warrants of its common stock equivalent to twenty percent (20%) of the amount of the Note based upon their current valuation. Security for the loan will be as per the terms of the convertible secured promissory note on RxMM's FDA approved, globally patented NeuroNasal medical delivery device, which forms an integral part of the Alzheimers Defense product system.

"For anyone who has watched a relative's or friends' memory disappear before them it is heartbreaking. If Alzheimer Defense helps prevent or slow down the process of memory loss it is a miracle. Redfund is excited to finance the building this revolutionary brand by RxMM and looks forward to supporting RxMM's other subsidiaries in the near future with additional funding ," stated Meris Kott, CEO.

[tzadoz2014]

Trotz der Meldung von Heute wurden an der Heimatbörse bislang gerade einmal 150 Aktien gehandelt. Scheinbar hat kaum jemand bislang diese Firma auf dem Zettel. Daher ist zu hoffen, dass alsbald eine der Firmen an die Börse geht. Das dürfte dann auch der Aktie von Redfund helfen.

Man kann übrigens in den nächsten Wochen/Monaten mit weiteren News zu RxMM rechnen. Aufgrund des Satzes der CEO: "and looks forward to supporting RxMM’s other subsidiaries in the near future with additional funding,” stated Meris Kott, CEO."

[tzadoz2014]

Auch wenn ich kein Fan von RockstoneResearch bin, stelle ich hier mal den Link rein. Da es in erster Linie nur eine Zusammenfassung (Stand 24.09.2018) der bislang veröffentlichten News ist und zudem eine Erklärung des Geschäftsmodells der Redfund.

http://rockstone-research.com/index.php/de/research-reports/…

[tzadoz2014]

Könnte hilfreich sein, um Redfund bekannter zu machen. Bei einer MCap von 24 Mio. ist ja noch keinerlei Phantasie und Zukunft im Kurs eingepreist.

https://web.tmxmoney.com/article.php?newsid=6654750492699369…

VANCOUVER, British Columbia, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Redfund Capital Corp (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) (Redfund or the “Company”) is pleased to announce that a Redfund Director will be moderating at the Institutional Capital & Cannabis Conference (IC3) and that the Company has committed to the first-ever cannabis gender equality funding strategy for women’s economic empowerment by financing women-led medical cannabis related companies.

This meaningful endeavour will focus on entrepreneurial women in the cannabis field. Numerous organizations have established platforms with the intent of helping women network, learn more about the industry, and collaborate together, and these groups have been very successful welcoming women into the cannabis space giving them the skillsets necessary to succeed. However, few have stepped up and committed to finance their companies.

Redfund is currently reviewing multiple women-led projects are currently under review and will be announced once promissory notes are signed and the companies become clients of Redfund.

“The funding of medical cannabis, CBD and hemp related companies remains the core focus of Redfund Capital,” stated Meris Kott, CEO.

[tzadoz2014]

Ganz unauffällig kommt Kunden um Kunde hinzu. Womit mindestens nette Zinseinnahmen generiert werden. Die Phantasie besteht aber natürlich weiterhin darin, dass eine der Firmen an die Börse geht und Redfund die Schulden in Aktien umwandelt.

https://web.tmxmoney.com/article.php?newsid=8631054166412945…

VANCOUVER, British Columbia, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Redfund Capital Corp (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) (Redfund or the “Company”) is pleased to announce that it has signed a promissory note with Mary’s Wellness Ltd. (“Mary’s”).

The Company

Mary’s Wellness is based in Ontario, Canada and was founded by Virginia Vidal in 2016. She was inspired to start the line of infused hot beverages to help manage her pain after the birth of her triplets in 2007. Since then, Mary’s brand has become synonymous as a symbol of wellness through cannabis.

Cannabis, if consumed by smoking is considered to be extremely harmful to the body. The active ingredients present in medical forms of marijuana can be infused into different types of liquids making drinks that can be used more regularly and whereby the medical constituents delivered through hot drinks reduce the psychoactive affects.

Mary’s current product line is 100% clean and organic, focused on medicinal cannabis and has a total of 18 varieties of convenient on-the-go brews with 12 packets in each box containing 60mg THC and 6mg CBD per serving. Flavours available are sleep & relax, bella coola, chamomile, chai, orange pekoe, lemon, peppermint, earl grey, plain green tea, green tea with ginger or ginseng, echinacea, berry berry, apple cider, hot chocolate, english toffee cappuccino, french vanilla cappuccino and coffee/java. For more information please visit www.maryswellness.com

The Investment

Redfund and Mary’s Wellness signed a 2 year term convertible secured promissory note on October 17th 2018 for CDN$1,000,000 at an annual interest rate of 12.5%. The Note may be converted at Redfund’s discretion at any time during the term and the Company has a right of first refusal to provide financing to Mary’s upon the same business terms as are being offered to Mary’s Wellness by any other funders. Mary’s will afford Redfund stock warrants in its common stock equivalent to twenty percent (20%) of the amount of the note based upon their current valuation as of the effective date which is stipulated to be CDN$2,000,000.

“We are pleased to welcome Mary’s Wellness to our portfolio of clients, now the second female led cannabis company. The Company continues to support innovative business owners that can easily create global footprints for their already established brands. Redfund will support Mary’s Wellness in their application for legal licensing for cannabis edibles in Canada. The Company will also assist Mary’s team with strategic relationships and help them export their IP and product brand to countries with already approved legal medical cannabis. We believe that Mary’s Wellness can become the world leader of cannabis infused tea and coffee,” stated Meris Kott, CEO.

Dragons’ Den Spotlight

Mary’s Wellness was featured on CBC’s Dragons’ Den television program, aired October 18th, 2018 the day after Cannabis Recreational Legalization in Canada.

[tzadoz2014]

Hier jetzt die Meldung auf Deutsch:
https://www.wallstreet-online.de/nachricht/10948546-redfund-…

Naja, und die hier übertreiben mal wieder maßlos. Ist aber auch nicht neu.
https://www.ariva.de/news/investment-in-kanadischen-hoehle-d…
Einzig interessant aus dem Artikel ist folgender Teil (wenn sie wirklich "zuverlässige" Info´s aus Unternehmenskreisen haben):

Unternehmenskreisen zufolge dürften zudem schon in wenigen Tagen die ersten Cannabis-Börsengänge angekündigt werden.

Denn genau diese IPO´s sind meine Hoffnung. So schön Einnahmen aus Zinsen auch sind.

[tzadoz2014]

News Ab nach Europa !

VANCOUVER, British Columbia, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Redfund Capital Corp (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) (Redfund or the “Company”) is pleased to announce the opening of its subsidiary First Euro Cannabis, the first medical cannabis incubator and accelerator in Europe, financing medical cannabis, CBD and hemp companies.

Redfund’s subsidiary First Euro Cannabis will be focused on sourcing the best investments into the growing market of companies in medical cannabis, CBD, and hemp.

Cultural differences and regulations need to be handled the right way and Redfund believes that their European team on the ground in Switzerland and London will assist the Canadian merchant bank to provide debt financing to companies currently in revenues or with sales in their pipelines to help jumpstart their business plans and growth organically. The new first if its kind going-global program of First Euro Cannabis will adapt to the needs and reality of these cannabis company scale-ups, designed to improve the chances for a successful first to market international branding launch for these companies across the pond to North America as well.

Tomorrow November 1st the UK approves legislation allowing specialist doctors such as neurologists and pediatricians but not general practitioners in England, Wales, and Scotland to prescribe medicinal cannabis to their patients, is foremost to Euro Cannabis spearheading the first funding into the medical cannabis space. These new laws will undoubtedly help patients with epilepsy, multiple sclerosis and nausea from cancer treatment if prescribed by their physicians. The stigma around medical cannabis remains an issue in the UK even with the change in the laws.

“A bad financing decision or strategic partnership can be fatal to any company and a small bridge loan has always been the right route to go for any company to step up to the next phase in their growth cycle. Redfund is hoping to raise over CDN$5,000,000 for First Euro Cannabis medical cannabis projects,” stated Meris Kott, CEO.

[tzadoz2014]

News
Die nächste Firma wurde an Land gezogen. Irgendwann dürfte/könnte sich dies auch mal bei der Aktie bemerkbar machen.

https://web.tmxmoney.com/article.php?newsid=6496938255354614…

VANCOUVER, British Columbia, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Redfund Capital Corp (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) (Redfund or the “Company”) is pleased to announce that it has signed a promissory note to fund Winterlife Inc. (“WL”) and their premier launch of WinterlifeCBD a branded new CBD and hemp based product line.

The Company

Winterlife Inc. has just launched the WinterlifeCBD product line that is free of THC, is 100% organic, vegan and gluten free. The SKUs will include Winterlife’s famous gourmet cookies, tinctures and capsules manufactured in Washington State.

Founded in 2013 in Seattle, Washington, Winterlife Inc. lead the early days of the cannabis legalization movement and quickly has gained international recognition for bold branding and quality products. Their items are currently available in 600+ dispensaries in Washington State and have processing agreements in multiple US states with revenues of close to CDN $3,000,000 per annum.

Winterlife recognized the present demand for familiarity and the future of consumption methods by developing products that could meet the consumers needs today, as well as positioning them to adapt to the future maturity of the industry. The trust they have garnered with the Winterlife brand in their products’ quality and efficacy has paved the way for the successful creation of the innovative products of WinterlifeCBD.

The Investment

Redfund and Winterlife Inc. signed a 2 year term convertible secured promissory note on November 1st 2018 for CDN$1,000,000 at an annual interest rate of 14%, The Note may be converted at Redfund’s discretion at any time during the term and the Company has a right of first refusal to provide financing to WL upon the same business terms as are being offered to Winterlife Inc. by any other funders. WL will afford Redfund stock warrants in its common stock equivalent to twenty percent (20%) of the amount of the note based upon their current valuation as of the effective date which is stipulated to be USD $5,000,000.

“Redfund is leading all merchant banks funding branded medical cannabis, CBD and hemp product lines that have the ability to go global today. Winterlife Inc.’s owners Charity and Evan Cox bring with them not only innovative products but an already successful history in the cannabis industry. They were the first ever to have a medical cannabis delivery system when few believed medicinal cannabis helped anyone. The Company is excited to work with such visionaries and their assistance footprinting our other branded clients will be a tremendous asset to the entire Redfund portfolio and team. As we look to the first quarter of 2019, a number of companies in our current loan portfolio are already assessing opportunities to become independently traded public companies. Redfund is evaluating all equity upside opportunities within our loan portfolio through the warrants and loan convertibility positions to directly maximize shareholder value,” stated Meris Kott, CEO.

[tzadoz2014]

Laut dem Update von heute, kann man mit einigen weiteren Unternehmensmeldungen in 2018 rechnen.

https://web.tmxmoney.com/article.php?newsid=7606164198241249…

Redfund Capital Update

Portfolio Companies Poised to go Public

Global Branded Products Focus

VANCOUVER, British Columbia, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Redfund Capital Corp (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) (Redfund or the “Company”) is pleased to share its 2018 Company update.

The Company Strategy

Redfund Capital is the first medical cannabis incubator and accelerator financing medical cannabis, CBD and hemp companies through a debt facility to bridge finance and help revenue producing medical cannabis related companies build their valuation, and grow their company without diluting their equity prematurely.

The core component of Redfund’s business strategy is to establish the foundation for a loan portfolio that not only generates revenues with monthly interest income from our loans to cover all the Company’s general and administrative expenses related to the day-to-day operations of the merchant bank, but to simultaneously grow our shareholder value by converting whole or part of our loans and warrants into equity in our portfolio clients as they build their valuations entering the public markets or become high priced targets of larger entities.

The Deals

Redfund is pleased to report it has already extended funds for 5 signed promissory notes and has over 11 companies in the pipeline at various due diligence stages. In accordance with notes signed with our clients not all terms details may be disclosed.

The Company loan portfolio consists of the following companies as of November 5th 2018:

Biolog Inc. (“BI”) a cannabis infusion technology company, based in Silicon Valley, California, that has developed a patented system to infuse food and beverages with cannabis, powered by Lexaria Bioscience Corp's DehydraTECHTM technology. Refund equity upside: with warrant exercise and note convertibility to acquire 10% of BI.

Biominerales Pharma Colombia (“BP”) the trailblazer in Colombia medical cannabis, that has the trifecta of licenses in Colombia allowing the company to grow, process and export CBD oil beyond South America to the global marketplace and is harvesting crop now. Redfund equity upside: with warrant exercise and note convertibility to acquire close to 30% equity in BP.

Mary’s Wellness Ltd (“MW”) founded by Virginia Vidal, a cannabis beverage trailblazer and a global medical cannabis influencer with a current product line of 100% organic items focused on medicinal cannabis and has a total of 18 varieties of convenient on-the-go brews. Redfund equity upside: ability to acquire through warrants and note conversion a substantial equity position once licensing is approved.

Winterlife Inc. (“WL”) founded in 2013 in Seattle, Washington, with close to CDN$3 million in sales through 600 dispensaries, has just launched the WinterlifeCBD product line that is free of THC, is 100% organic, vegan and gluten free. Redfund equity upside: through the promissory note convertibility feature if exercised, has the ability to acquire 50% of Winterlife Inc.

RxMM Health Care a division of RxMM Health Capital involved in manufacturing of CBD over-the-counter medications, and Alzheimers Defense (AD) a proprietary, CBD infused "all natural" nutraceutical product. Refund upside: note collateralized by intellectual property assets third party valued at over USD$40 million.

The 2019 Vision

Redfund Capital’s opportunity in emerging markets and the unique market conditions in the cannabis industry make it possible for the Company to uniquely grow in the first quarter of 2019. Two of the companies in our present portfolio are already investigating the step by step process to file applications to the Canadian Securities Exchange and hope to become stand alone public companies in the first quarter. The ability to convert our notes and warrants into equity of these companies and the first right of refusal on all debt and equity will enable Redfund to continue to create a strong upside potential for our shareholders. Redfund will press information as it becomes publically available and as the Company converts its equity positions.

The Company is in the right space at the right time. Redfund has a clear value of what the Company brings to the market and to the Redfund shareholders. The ROI on any new emerging market, tends to be a year or more down the line. The opportunity to gain market share will never be greater than when a market is newly emerging and cannabis globalization is already here and will only expand in the coming year.

“The Company vision is to have a portfolio of 20 companies with $75 million injected through loans deployed to companies who have commonalities of revenues, brand awareness, and a keen interest to go global with their products. We know the opportunity operating as an international business and continuing to invest in that future concept is advantageous to our shareholders. The hot IPO scenario is actually still in its infancy for the medical cannabis industry as it mainstreams, and we are looking forward to our portfolio companies being leaders in the public markets,” stated Meris Kott, CEO.

[tzadoz2014]

Meldung vom 09.11.2018
(Keine neue Finanzierung. Nur deren Einschätzung zum Wahlergebnis in den USA, bezogen auf deren Firma .)

https://web.tmxmoney.com/article.php?newsid=8102712284516641…

VANCOUVER, British Columbia, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Redfund Capital Corp (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) (Redfund or the “Company”) reflects on the positive impacts on the Company of the United States election results.

Redfund Capital is focused on funding Medical Cannabis, THC-free CBD and HEMP related companies. The Company considers the recent USA increase in individual states approving the prescription of medical cannabis to patients a major milestone for the industry and in turn, for Redfunds portfolio of clients who lead the global cannabis health initiative. Redfund looks forward to medical practitioners having the ability to prescribe once taboo cannabis medicines in more jurisdictions, thus bringing attention to medically beneficial usages.

The USA midterm elections passed medical cannabis ballot proposals in two states this week, including legalized recreational pot in Michigan. Voters in the states of Utah and Missouri decided patients should have access to medical marijuana and joined many other American states with the adoption of comprehensive medical marijuana programs, making it 33 states plus the territories of Guam, Puerto Rico, and the Northern Mariana Islands and the District of Columbia with some level of ability to prescribe cannabis for specific conditions.

Novel cannabis delivery systems like the disruptive cannabis infusion technology of Biolog Inc. will gain large traction throughout the USA; Biolog Inc. funded by Redfund and press released by the Company September 26th, 2018. Products like that of RxMM Health Care’s Alzheimer's Defense, a proprietary, CBD-infused all-natural nutraceutical product will increase sales across the country with more exposure in the medical communities; RxMM funded and press released by the Company October 9th, 2018.

An ever-increasing number of patients worldwide are using cannabis for therapeutic reasons. On November 1st the UK proclaimed acceptance of medical cannabis prescribed by neurologists and specialized physicians who joined the global community by pushing medical marijuana forward into the European mainstream. By example, Redfund portfolio client Mary’s Wellness teas, a product which Redfund will assist in creating a brand new presence in the UK as a medicinal option, is a fine example of our continuing drive to expand the portfolio. Mary’s Wellness teas was funded and press released on October 22nd, 2018.

“The Company’s vision is to help our portfolio companies expand their sales beyond country borders. We believe the midterm elections are a positive sign to all of us that the United States will mainstream medical cannabis in the very near future and we look forward to expanding into markets supporting these initiatives,” stated Meris Kott, CEO.

[tzadoz2014]

https://web.tmxmoney.com/article.php?newsid=5573013655630918…

VANCOUVER, British Columbia, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Redfund Capital Corp (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) (“Redfund” or the “Company”) is pleased to update operations of Mary’s Wellness Ltd. (“Mary’s”), best in class cannabis infused tea beverage company.

As more countries enter the medical cannabis legalization phase, endorsements that cannabis is a source of treatment and relief from conditions like anxiety, insomnia, and pain will continue and enable branded products like Mary’s Wellness to succeed in global markets.

Redfund is in active discussions with partners in the UK, Switzerland, Colombia and Portugal to help launch Mary’s products. The Company will work closely with Mary’s team to make sure all work is ethically sourced by using third party metrics from groups like the UN Human Development Index and the International Labor Association to evaluate the ethics and quality of the companies that it sources for its tea and coffee products.

Mary’s is working with their legal team in preparation of filing documentation to the Canadian Federal government when regulations on new licensed classes of cannabis for edibles is made available to qualified applicants. Mary’s is also in discussion with various Canadian LPs (licensed cannabis producers) to produce their infused tea products once licensing approval is granted. Canada’s October 2018 legalization of cannabis opted to limit purchases to dried or fresh cannabis and cannabis oil from government approved licensed retailers. Canadians can also make cannabis products, in food and drinks, for personal use.

“We are excited for the opportunity to share our original Canadian infused tea blends and our family brand with the world’s most renowned tea enthusiasts from Europe to South America,” said Virginia Vidal, Founder and CEO, Mary’s Wellness Ltd.

“Tea has always been the feel good go-to-brew for a healthy lifestyle. Creating a worldwide brand like Starbucks is exactly what we are planning with Mary’s. Our goal for the first quarter of 2019 is to finance and list Mary’s Wellness Ltd. on a public exchange. Promoting cannabis infused medicinal teas will be a very rewarding team effort and we are looking forward to it,” said Meris Kott, CEO.

Redfund Capital announced that it completed its first financing with Mary’s Wellness Limited on October 22nd 2018. Redfund and Mary’s signed a 2 year term convertible secured promissory note on October 17th 2018 for CDN $1,000,000 at an annual interest rate of 12.5%.

[tzadoz2014]

News
Winterlife plant für das 2. Quartal 2019 den Börsengang

https://web.tmxmoney.com/article.php?newsid=5717986311853215…
Second Redfund Portfolio Client Set to List On Public Markets Benefiting All Redfund Shareholders

VANCOUVER, British Columbia, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Redfund Capital Corp (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) (“Redfund” or the “Company”) is pleased to update operations of Winterlife Inc. and WinterlifeCBD (“WL”)

Although THC is popular, marijuana itself has more than 60 cannabinoids, each with its own known set of healing effects. High CBD and low THC products have very minimal psychoactive effects. In cannabis, other than THC, CBD is the most common cannabinoid and is well known to treat, help and prevent seizures, nausea, anxiety, depression, inflammation, psychosis, and is believed to prevent cancer. With over 33 states now having medical cannabis programs, the reality of CBD healing powers are finally surfacing.

Many practitioners continue to prescribe CBD while waiting for the world to fully legalize CBD treatments for pain and other solutions. Winterlife has responded to this need with an inventive assortment of high CBD products with their launching of WinterlifeCBD.

WL is embarking on a vast, multi-state USA expansion by branding a new set of WinterlifeCBD products and a Canadian introduction, once CBD is acceptable in edibles in the country. Additionally, with the advisory services of Redfund’s First Euro Cannabis, the European subsidiary launch for its clients’ CBD products, will be organized with a jump-off in Switzerland where CBD products have been implemented and are currently being sold in most retail stores including international airports.

“The Winterlife brand exuberates a crisp and clean natural feeling. Organic and vegan to appeal to the free spirit of many patients including millennials looking to find a solution to their stress and anxiety conditions. With a goal of helping Winterlife become a public company in the second quarter of 2019, this superior brand will be easily identifiable as any other national or globally recognized cookies and snacks company,” stated Meris Kott, CEO, Redfund Capital Corp.

Redfund Capital announced that it completed its first financing with Winterlife Inc. on November 5, 2018. Redfund and WL signed a 2 year term convertible secured promissory note on November 1, 2018 for CDN $1,000,000 at an annual interest rate of 14% .

[tzadoz2014]

NEWS

Das könnte helfen, Redfund bekannter zu machen.

https://web.tmxmoney.com/article.php?newsid=7569571901158875…

Coverage Initiated for Redfund Capital Corp. via NetworkNewsWire

NEW YORK, Nov. 15, 2018 (GLOBE NEWSWIRE) -- via NetworkWire - Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4), a merchant bank focused on providing debt and equity funding in the mid to late stages of a target company’s development and for technologies that are developed and validated by revenues, announces that it has engaged the corporate communications expertise of NetworkNewsWire ("NNW").

Redfund’s current focus is on medical cannabis, hemp and cannabidiol (CBD) related and healthcare-related companies. As the first medical cannabis incubator and accelerator financing medical cannabis, CBD and hemp companies through a debt facility, Redfund is effectively bridging finance gaps and helping revenue-producing medical cannabis-related companies grow and build their valuations without prematurely diluting their equity.

NetworkNewsWire is a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. NNW’s strategies help public and private organizations find their voice and build market visibility. As part of the Client-Partner relationship with Redfund, NNW will leverage its investor-based distribution network of over 5,000 key syndication outlets, various newsletters, social media channels, blogs, and other outreach tools to generate greater brand awareness for the company.

“Redfund has years of experience in business, consulting, capital markets, corporate finance and healthcare services. As the company uses this expertise to create global companies backed by strong fundamentals, we will execute a corporate communications campaign that keeps the investment community up-to-date with its progress,” states Sherri Franklin, Director of Client Solutions for NNW.

[tzadoz2014]

News
Mittlerweile bringt Redfund ja fast täglich eine Meldung raus.
Mal sehen, ob denn eine der drei in der Meldung genannten Firmen demnächst eine Finanzierung über Refund abschliesst.

https://web.tmxmoney.com/article.php?newsid=7143016952716034…

Redfund Capital Welcomes Israeli Medical Cannabis Financing Opportunities

Massive Breakthrough To Represent and Finance Best in Class Opportunities

VANCOUVER, British Columbia, Nov. 16, 2018 (GLOBE NEWSWIRE) -- Redfund Capital Corp (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) (“Redfund” or the “Company”) comments on Israel allowing the medical export of its products to global markets.

Since the 1990’s medical cannabis in Israel has been prescribed to patents with pain-related illnesses such as Parkinson's, multiple sclerosis and other chronic pain and post-traumatic stress disorders. In April 2018 it was discussed that Israel would approve its first medical cannabis export of products such as capsules and oils but not raw marijuana. Many Israeli farmers applied for medical cannabis farming and marketing licenses expecting the reform to go through, but the gridlock has been exhausting for them. Israelis began to farm and develop cannabis companies outside the country.

The Israeli approval has been held up despite near unanimous support for the idea in the government. Today, it was announced that the medical cannabis bill will finally go on the Knesset agenda for first reading and the Minister of Public Security, Gilad Erdan and Internal Affairs and Environment Committee chairperson, Yoav Kisch (Likud) agreed to promote the bill.

Redfund has been compiling its final due diligence protocols around several already identified Israeli clients to become portfolio companies with a growth strategy into North America and Europe. One is a technology company which changes how medical cannabis is grown for medical cannabis patients, the next a medical products and CDB company, and the third an agricultural grow who has operations abroad and its research and development facilities in Israel.

Meris Kott, CEO of Redfund commented, “We are looking to Israel as our next country to forge strong relationships with for our banking initiatives. Israel has always led with a strong generic drug footprint. I am looking forward to working closely with partners in Israel in the very near future and capitalizing on current opportunities.”

[tzadoz2014]

https://web.tmxmoney.com/article.php?newsid=6258508661187385…

Redfund Capital Corp. Discusses Cannabis Banking in Exclusive Audio Interview with NetworkNewsWire

The interview can be heard at: https://www.globenewswire.com/Tracker?data=MS1WhnTike2i2AD2E…

[tzadoz2014]

News

https://web.tmxmoney.com/article.php?newsid=8834697468934948…

Redfund Capital Client Biolog Inc. and Cannabis Strategic Ventures Inc. Announce Joint Development of Water-Soluble Cannabis Technology

VANCOUVER, British Columbia, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Redfund Capital Corp (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) is pleased to announce that portfolio client Biolog Inc. has formed a partnership with Cannabis Strategic Ventures, Inc. (OTC:NUGS), to develop water-soluble cannabis technologies to be used as ingredients for cannabis and phytocannabinoid rich-infused foods, beverages and consumer products. Under the agreement, Biolog will develop the new technologies with Cannabis Strategic Ventures and will jointly deploy marketing efforts to get the products to the marketplace.

Cannabinoids (CBD, etc.) are hydrophobic substances which are not typically soluble in water. To date, cannabis formulators have utilized various techniques to make CBD oils water compatible, but encounter many drawbacks in the existing processes. The joint development effort between Biolog Inc. and Cannabis Strategic Ventures will seek to push past these current limitations to develop a new set of functional cannabinoid ingredients that can be easily added to foods, beverages, cosmetics and other consumer products that significantly improve bioavailability and overall benefits to the human body.

Simon Yu, CEO, Cannabis Strategic Ventures comments, "We believe water-soluble cannabis technologies open new avenues for the development of cannabinoid-based products.” He added, “Over the past year we have reviewed several supposed water-soluble cannabinoids technologies but have passed on adoption due to technological limitations. The new product class that is in development with Biolog holds great potential and we are enthusiastically backing this developmental effort.”

“Working alongside Cannabis Strategic Ventures and assisting them to realize their mandate building their products brands using Biolog technology shows collaboration of incubators in the space. Branded products are the niche we believe will lead the industry just as patented medical products lead pharma for many decades. Biolog’s licensing agreements with Lexaria makes them a leader of the medical cannabis pack. This client in our portfolio looks to be our next go-public prodigy,” stated Meris Kott, CEO, Redfund Capital Corp.

[tzadoz2014]

-29,21%
Mittlerweile bin ich hier ordentlich im Minus. Verkaufen ? Nein. Ich warte auf die geplanten IPO's. Bei den geringen Umsätzen gab es größere Kurssprünge schon mehrfach. Wenn auch nicht solch ein großer.

[tzadoz2014]

Mal wieder was neues von Redfund

https://web.tmxmoney.com/article.php?newsid=5706579903149818…
VANCOUVER, British Columbia, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Redfund Capital Corp (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) (“Redfund” or the “Company”) highlights tremendous speaking engagements to close out 2018.

O’Cannabiz Conference and Expo: Vancouver December 10th and 11th 2018

O’Cannabiz is a gathering of the people putting Canada on the worldwide cannabis industry map and creating momentum in a new marketplace. One of the keynote speakers is Montel Williams. He is one of the highest profile advocates for cannabis in the USA. He has used cannabis products to effectively manage the symptoms of his chronic illness since his diagnosis in 1999. As a military veteran, over the past two decades, he has worked to pass cannabis legislation in key states and led the push for military veterans to access medical cannabis without the threat of losing benefits. www.ocannabiz.com

Virginia Vidal, CEO of Mary’s Tea, will be speaking on the edibles, infused foods and beverages, hurdles and rewards as a head panelist.

Amanda De Freitas, Redfund Director and Meris Kott, Redfund CEO and Director are discussing the future of cannabis currency and the ability to digitally track supply chains, sales and transactions.

“O’Cannabiz is more about medical cannabis than any other show and it is what differentiates Redfund from other funders as we are focused on financing medical cannabis. For Virginia Vidal, this has never been about a job, and it was more of a calling from the beginning to help others who could benefit from her medicinal infused tea. We look forward to supporting her team into 2019. As we close out the year, this is just one more milestone we have reached, 3 women all involved with Redfund speaking at a cannabis event,” stated Meris Kott, CEO, Redfund Capital Corp.

[tzadoz2014]

Update

https://web.tmxmoney.com/article.php?newsid=7873601818013326…
VANCOUVER, British Columbia, Dec. 12, 2018 (GLOBE NEWSWIRE) -- Redfund Capital Corp (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) (“Redfund” or the “Company”) announces strategic alliance between Winterlife Inc. and Mary’s Wellness Ltd. to begin global cannabis products launch.

Cannabis industry observers feel that we are on the threshold of what could be a global branding battle. Redfund is pleased to announce that two of our investments representing branded cannabis products, Winterlife Inc. and Mary’s Wellness Ltd. have collaborated together to form a strategic alliance to first launch Mary’s Wellness a well known Canadian tea brand into the USA. Both brands represent the best in class with their product lines.

Winterlife is embarking on their own vast, multi-state USA expansion by branding a new set of Winterlife CBD products, that is free of THC, is 100% organic, vegan and gluten free, and a Canadian introduction, once CBD is acceptable in edibles in the country. Winterlife’s famous gourmet cookies, tinctures and capsules manufactured in Washington State will all be available as SKUs.

Mary’s Wellness current product line is 100% clean and organic, focused on medicinal cannabis and has a total of 18 varieties of convenient on-the-go infused brews and is poised to launch into the USA immediately through the Winterlife alliance.

"In business, cooperation is the key to growth. Mary's Wellness stands out as a complementary brand to Winterlife Cannabis and Winterlife CBD. We are excited to help Virginia launch her infused brew on-the-go tea products into Washington State and expand nationally. Our consumers will benefit from a wider selection of healthy natural products,” said Charity Cox, Winterlife Inc.

"Mary’s Wellness is an experience into traditional authenticity; our family is beyond happy to bring our portfolio of Cannabis Wellness Beverages to an expanded market with the assistance of Winterlife Inc. We can also look forward to continued growth into a global brand with Redfund," stated Ricardo Batho, Mary’s Wellness Ltd.

“The emphasis on globalization for Mary’s Wellness signals Redfund’s commitment to our rapidly growing array of international clients in our portfolio. Helping companies organically grow and build their valuation by increasing their revenues has always been at the core of our business model. We look forward to Winterlife’s national expansion and Mary’s Wellness launch abroad and both companies looking to the Public Markets for their own listings in 2019,” stated Meris Kott, CEO, Redfund Capital Corp.

[bohrmeister]

bin sehr enteuscht dieser absturz war in der meinung es geht ein bischen aufwärts
allen einen schönen tag

[tzadoz2014]

Antwort auf Beitrag Nr.: 59.460.264 von bohrmeister am 18.12.18 09:36:49

Zitat von bohrmeister: bin sehr enteuscht dieser absturz war in der meinung es geht ein bischen aufwärts
allen einen schönen tag

Man muss leider warten, bis das erste Unternehmen an denen Redfund beteiligt ist, an die Börse geht. Wenn das erfolgreich ist und die MCap beim IPO hoch genug ist, könnte Redfund einen Kurssprung vollziehen. Bis dahin muss man sich aber wohl gedulden.

[bohrmeister]

Antwort auf Beitrag Nr.: 59.460.519 von tzadoz2014 am 18.12.18 10:09:47

Danke für die Info also das heist Geduld
nochmals danke

[tzadoz2014]

So langsam dürften sie mal eine neue/weitere Finanzierung einer Cannabis-Firma veröffentlichen. Die letzte Meldung hierzu ist jetzt schon einige Wochen her. Zudem dürften sie ruhig auch mal einen Finanzbericht per 30.09.2018 veröffentlichen. Da wird es zwar noch nicht viel zu sehen geben. Aber trotzdem.

[SVTimo]

Hier passiert wohl nix🤷‍♂️

[tzadoz2014]

Antwort auf Beitrag Nr.: 59.614.703 von SVTimo am 12.01.19 08:29:38

Zitat von SVTimo: Hier passiert wohl nix🤷‍♂️

Ja, aktuell ist hier tote Hose. Wäre mal an der Zeit, wenn das erste Unternehmen einen Börsengang ankündigt. Das dürfte dann auch Redfund wieder auf die Sprünge helfen. Und die Stimmung am Markt ist aktuell ja wieder deutlich besser. So das ein IPO auch erfolgreich verlaufen könnte.

[bohrmeister]

also Ich sehe das auch so hier passiert leider nichts die müssten mal Arbeiten anfangen
jedem eine erfolgreiche woche

[tzadoz2014]

Der Finanzbericht per 30.09.2018 ist immerhin jetzt da. Es wird also noch dort gearbeitet. Der Inhalt ist natürlich noch ziemlich uninteressant.
http://stockhouse.com/companies/filings?symbol=c.loan

[SVTimo]

Was macht ihr hier so? Liegen lassen und abwarten? Verkaufen? Oder noch etwas nachkaufen?

[tzadoz2014]

Antwort auf Beitrag Nr.: 59.808.429 von SVTimo am 06.02.19 19:47:56

Zitat von SVTimo: Was macht ihr hier so? Liegen lassen und abwarten? Verkaufen? Oder noch etwas nachkaufen?

Aktuell "Halten"

[tzadoz2014]

News

Es gibt tatsächlich mal Neuigkeiten. Dann hoffen wir mal, dass diese neue Partnerschaft wieder für einen größeren Newsflow sorgt. Volumen an der Heimatbörse gestern immerhin 255.000 Aktien. Das ist für Redfund Verhältnisse eine sehr große Zahl. Nachkaufen werde ich aber vorerst trotzdem noch nicht.

https://web.tmxmoney.com/article.php?newsid=6924313252500566…
VANCOUVER, British Columbia, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Redfund Capital Corp (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) (“Redfund” or the “Company”) announces new USA focused plan in CBD and Hemp.

Redfund Capital is pleased to announce the Company has engaged New Jersey based Wingspan Advisors and Jerry Hug. Mr. Hug is currently Director of Global Operations for Cloud Commerce, a data driven digital marketing company in the United States. Through it’s wholly owned subsidiaries Parscale Digital, Datapropria, Giles Design and WebTegrity, Cloud Commerce provides data-driven digital marketing services, content creation and media buying to its clients. Prior to joining Cloud Mr. Hug was Chief Executive Officer of SITO Mobile a location based mobile advertising company where he architected a transformation of the company which enabled an uplisting to the NASDAQ. From 2003 to June 2006, Mr. Hug served as Executive Vice President and Chief Strategy Officer of Wireless Retail Inc.; an Arizona based $400 million wireless services company that was sold to the Radio Shack Corporation.

Mr. Hug will be Redfund’s first advisor to the Company’s newly formed USA advisory team. He will help advise Redfund on how to position the Company’s current loan portfolio of branded products throughout the USA. The Redfund team will focus on the CBD and hemp sector and help the Company target new opportunities for investments in the USA. Mr. Hug’s first project will be to help establish a working relationship with partnerships in the USA for Redfund’s current portfolio companies and help them footprint the entire country.

New Frontier Data’s estimates that, the hemp-derived CBD market will grow from a $390 million-dollar market in 2018, to a $1.3 billion market (or 3.3x) by 2022, representing a 27.2% 5-year CAGR. (Hemp Business Journal)

“Redfund Capital is converting our strongest portfolio client loans into equity company positions this month. As we build our American footprint, the Company has also begun our application to the OTCQB. We are excited to welcome Jerry to our team and his input and experience will be an invaluable asset to our growth,” said Meris Kott, CEO.

Mr. Hug added, “We have already begun the process of developing a comprehensive plan for Mary’s Wellness to launch a CBD infused Tea line in the USA which includes contract manufacturing, retail distribution, and e-commerce. This process will serve as the playbook we will replicate for the other many brands in the Redfund portfolio.”

[ShelbyCobra]

Antwort auf Beitrag Nr.: 59.757.507 von tzadoz2014 am 31.01.19 15:53:25

Lest euch den Finanzbericht mal genau durch! Vor allem Seite 13, Punkt 5. Eine Gesellschaft zu erwerben, die keinerlei Geschäfte macht und deren Eigentümer Meris Kott ist, für fast 2 Mio! Seitdem bin ich raus!

[tzadoz2014]

Antwort auf Beitrag Nr.: 59.836.687 von ShelbyCobra am 10.02.19 16:00:51

Kann ich durchaus nachvollziehen.
Ich warte aber trotzdem mindestens das erste IPO ab. Bei der geringen MCap von Redfund könnte das für einen Kurssprung sorgen. Jen achdem mit welcher Bewertung die dann an die Börse gehen.
Aber klar ist, dass Redfund aktuell nur etwas für Anleger ist, die Geduld mitbringen und einen Hang für spekulative Aktien haben.

[tzadoz2014]

Der Kursverlauf ist ein einziges Trauerspiel. Hatte mir echt schnellere Fortschritte hier erwartet. Hoffen wir jetzt mal, dass die Zusammenarbeit mit dem CEO of Wahupta langsam mal Leben in die Bude kommt. Verkauft habe ich meine Anteile noch nicht. Bin aber mittlerweile schon froh wenn ich meinen Einsatz wieder rauskriege. Der Heben für Kurssteigerungen ist bei dieser, mittlerweile geringen MCap natürlich groß. Nur dazu muss unbedingt mehr passieren.

https://web.tmxmoney.com/article.php?newsid=4807292062916476…

Redfund Capital Provides Corporate Update

VANCOUVER, British Columbia, Feb. 15, 2019 (GLOBE NEWSWIRE) -- Redfund Capital Corp (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) (“Redfund” or the “Company”) provides corporate update plus first quarter client financing rundown.

Redfund Capital is pleased to announce Warren D. Cudney, CEO of Wahupta Ventures Inc. to our advisory team. He is recognized as a leader in corporate start-ups and is a speaker in the field of health and wellness, most recently specializing in the emerging hemp and CBD oil and isolate industry throughout North America and the world. As a top C level strategist in this field, Warren is intimately involved with strategic planning and implementation, as well as acting as a key team player in managing this highly specialized field from genetics to finished product development. He is devoted to industry-leading quality control, ensuring that the team vision and corporate goals are continuously met, and creating an environment that ensures excellence in the industry.

Wahupta has been creating a hemp buzz in the western Canadian prairie fields for almost 2 years. As released by Wahupta on January 11th 2019, in its first year in operation, Wahupta harvested an unparalleled 975 acres of hemp and amassed 2.5 million pounds of hemp biomass. Redfund has been advising Wahupta for the past year.

In our First Quarter, Redfund Capital has extended funds to three cannabis companies. The amounts Redfund has advanced to date under the loan facilities, which are specifically designed to be issued in tranches as the investee company advances and reports on its business plan. They are as follows:

RxMM Health, entered into a USD $500,000 promissory note on October 1, 2018 and were extended a first tranche of CDN $220,740.

Mary’s Wellness Ltd., entered into a CDN $1,000,000 promissory note on October 15, 2018 and were extended a first tranche of CDN $100,000.

Winterlife Inc., entered into a USD $1,000,000 promissory note on November 1, 2018 and were extended a first tranche of CDN $100,080.

“Redfund Capital is in the process of converting portfolio client loans into equity positions and building our global brand. As an incubator, it is our role to help our clients increase their current valuations and grow organically to the next cycle in their lifespan. In prior press releases we indicated the intent of some portfolio companies to go public. Such disclosure indicates only their stated intentions to us, and each is responsible for making their way onto the public exchanges. We believe Wahupta may be the next breakout leader in the hemp sector, and with their vertical operations and farm to field to consumer vision we are very proud to have them as a client in our portfolio and welcome Warren to our advisory team,” said Meris Kott, CEO.

[tzadoz2014]

Passt da meine Thread-Überschrift noch ? Ich dachte, man wolle eine Mischung aus Cannabis-Bank bzw. Beteiligungsgesellschaft sein.
Naja, wenn es dem Kurs helfen sollte, kann ich damit auch leben.

https://web.tmxmoney.com/article.php?newsid=6834853491096755…
VANCOUVER, British Columbia, Feb. 18, 2019 (GLOBE NEWSWIRE) -- Redfund Capital Corp (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) (“Redfund” or the “Company”) launches new beverage division.

Within its global expansion plan, Redfund Capital is filling a key gap in the market for lifestyle-driven infused beverages as demand for upscale hospitality and health-wellness sectors start to boom. This foray of products will be the hemp market’s solution for the search of high quality items. Our products will be manufactured with the latest technology, where we have strategic alliances and where we will provide the raw materials.

The Company’s first beverage product group will consist of powdered flavored hemp seed and hemp infused teas. Hemp based protein powders have been popular as nutritional supplements used by athletes, bodybuilders and those looking to grow and stay healthy.

“Reports suggest the entire hemp-derived CBD market will hit $22 billion globally by 2022. Much of the focus on CBD-infused products and drinks is towards the healthy lifestyle consumer market. However, more big brand beverage companies are expected to enter the industry and create CBD-infused non-alcoholic beverages for a broader spectrum of consumers. CBD-focused developments and partnerships are likely to increase as industry regulation becomes clearer.” (CannabisNewsWire 1/15/19)

“The launch of our own proprietary beverage product-line has been in the works for almost a year. This division will provide the go forward business development advisory services as an added benefit to portfolio clients,” said Meris Kott, CEO.

[tzadoz2014]

News

Partnerschaft mit Wahupta wird ausgebaut

https://web.tmxmoney.com/article.php?newsid=4872676365597408…

VANCOUVER, British Columbia, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Redfund Capital Corp (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) (“Redfund” or the “Company”) expands their current advisory agreement with Wahupta Ventures Inc. to include new financing.

Redfund Capital agrees to invest up to $1,000,000 into Wahupta Ventures Inc. and the proceeds to be used to help build their extensive and growing Canadian hemp footprint.

Wahupta Ventures Inc. is headquartered in Canada and the US, with offices located in Winnipeg Manitoba, Vancouver, British Columbia, and Orange County, California. Wahupta is focused on the cultivation, production, processing, and extraction of hemp and cannibidiol (CBD), while simultaneously creating key collaboration with sovereign Indigenous communities throughout North America. It is Wahupta’s core value to work with its partners to develop emerging opportunities that do not currently exist in communities. They have established strategic joint ventures, partnerships, and made acquisitions, which positions Wahupta to be a hemp industry leader from farm to table with CBD and hemp products. Their partnership with Canadian based hemp food manufacturer Naturally Splendid Enterprises gives them access to the extensive North American supply chain with numerous points of distribution.

“We believe strongly in the team and their vision at Wahupta, and are eager as well to work with their partner Naturally Splendid in developing client and proprietary hemp products. We look forward to helping assist Wahupta to the next level of their strategic plan with additional capital,” said Meris Kott, CEO.

[tzadoz2014]

Nächste Meldung.
Richtig Freude wird aber erst aufkommen, wenn eine der Investments tatsächlich an die Börse geht. Denn darauf warte ich als Anleger nur. Immerhin geht es aber langsam nach oben. Von meinem Kaufkurs bin ich allerdings noch "etwas" entfernt.

https://web.tmxmoney.com/article.php?newsid=5236202711895285…
VANCOUVER, British Columbia, Feb. 24, 2019 (GLOBE NEWSWIRE) -- Redfund Capital Corp (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) (“Redfund” or the “Company”) is pleased to share that our client Wildflower Brands products were chosen for the 2019 Oscars Four Seasons Hollywood Swag Bag.

Wildflower Brands Inc. (CSE: SUN) (OTC: WLDFF ) was founded in Vancouver, Canada in 2012. Their products incorporate the synergistic effects of plants and their extracts and are manufactured in the USA in GMP facilities and are third-party lab tested for quality assurance and accurate labeling. Wildflower was selected to provide gifts for the nominees, presenters and talent staying at the luxury Four Seasons Hotel Los Angeles for the 2019 Oscars. The talent will receive their Hollywood Swag Bag luxuries in the comfort of their hotel rooms pre-show. The swag bag this year includes an assortment of Wildflower CBD products, and both hemp-based CBD products contain less than .03% THC. The unique Cool Stick offers quick and convenient relief from muscle, joint, and back pain and the CBD Healing Stick is formulated with therapeutic essential oils like arnica and wintergreen, to help combat acute and stubborn pains and inflammations. (www.buywildflower.com)

Redfund Capital’s incubator program includes marketing initiatives plus exposure of our clients’ brands to help footprint them globally. The Company is fortunate to partner with Karen Lee, the founder of Kaleidoscope Health and Ripped Femme, who has over 10 years experience in formulating and creating nutritional products. She made it possible for the Wildflower products to be featured in a talent give-away products bag for the 2019 Oscars. (www.rippedfemme.com)

“It is exciting to see Canadian companies such as popular Wildflower featured on the worldwide stage as CBD products become mainstream in the retail US marketplace. I want to thank Karen for this marketing opportunity and look forward to her continued support with Redfund’s accelerator and incubator programs. Exposure for our clients’ branded products is key to their successes,” said Meris Kott, CEO of Redfund Capital Corp.

[tzadoz2014]

Das nächste Unternehmen an Land gezogen
Nach einer kleinen Durststrecke häufen sich jetzt wieder die Meldungen. Dann hoffe ich mal, dass sich dies auch irgendwann beim Kurs bemerkbar macht.

https://web.tmxmoney.com/article.php?newsid=5821543888875305…
VANCOUVER, British Columbia, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Redfund Capital Corp (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) (“Redfund” or the “Company”) has signed a term sheet and has agreed to fund CANNAKI BEVERAGE INC. a nano CBD flavored water company.

CANAKI BEVERAGE COMPANY, INC., http://cannaki.com more commonly known as CANNAKI®, manufactures natural and organic functional beverages. Based in Las Vegas, USA, the Nevada company’s core products are still and carbonated beverages and specialize in Nano CBD infused flavored water. Their CBD is farm-direct and ISO certified to contain Zero THC. CANNAKI also manufactures and sells other organic, kosher and vegan products and soon launching a new line of Hemp and Guayusa beverages in April 2018. Their mission is to make great tasting beverages without sacrificing quality. To blend botanical nutrition with “KI” natural goodness. To create a world of beverages with integrity and transparency — with no limits on taste, quality, geography or imagination. CANNAKI’S core values guide them in their quest.

“Global bottled water market was valued at $198.4 million in 2017, and is expected to reach $307.3 million by 2024, expanding at a CAGR of 6.4% during the forecast period 2024 End. Bottled water is packaged drinking water that is purified and free from contamination. It is available in plastic and glass water bottles, and is the most convenient way for the body to fulfill its hydration needs being easily available in nearby retail stores and supermarkets. (https://www.researchreportinsights.com/report/rd/110114577/B…

Redfund Capital has signed a convertible note term sheet with Cannaki Beverage Company for USD $1,000,000 at a rate of 14% interest with a term of 2 years. Redfund and Cannaki will be finalizing a promissory note and security document in the next week and will disclose details of the completed transaction at that time.

“Partnering with a water company with a strong footprint is a tremendous opportunity for Redfund. Cannaki has one of the largest varieties of water based SKUS in the marketplace and is continuing to increase their varieties. Cannaki has still, sparkling, flavored, plus Pet water, and a global presence as well. Redfund has filed an OTCQB listing application in order to continue to build our US presence. ” stated Meris Kott, CEO.

[tzadoz2014]

Die Zahlen per 31.12.2018 wurde veröffentlicht. Natürlich, wie zu erwarten, nicht sonderlich interessant. Es hat sich ja nichts geändert. Es MUSS das erste IPO her. Dann kann es hier ganz schnell sehr weit nach oben gehen. Je nachdem wie erfolgreich der IPO verlaufen würde.
https://stockhouse.com/companies/filings?symbol=c.loan

[tzadoz2014]

News

https://web.tmxmoney.com/article.php?newsid=6024471990882052…
Redfund Converts Loan into Equity Position in Mary’s Wellness Ltd.

[tzadoz2014]

Die Hoffnung macht der rot markierte Teil. Denn bislang hatten sie immer direkt die Bedingungen genannt. Diesmal werden sie erst in den nächsten Tagen die Bedingungen für diesen Deal nennen. Damit habe ich die Hoffnung, dass dies mal etwas "größeres" ist. Wäre ja schön. Denn aktuell stehe ich noch ordentlich im Minus, über 50%. Wenn ich mit +/- Null rauskomme, wäre ich schon zufrieden. Da Redfund entgegen meiner Erwartungen bislang noch nichts gerissen hat. Auch bei deren bisherigen Investitionen gab es noch keinen, von mir, erhofften IPO.

https://web.tmxmoney.com/article.php?newsid=4993805606167965…
VANCOUVER, British Columbia, March 20, 2019 (GLOBE NEWSWIRE) -- Redfund Capital Corp. (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) (“Redfund” or the “Company”) is pleased to announce a strategic alliance between the Company and the Cannabis Mercantile Exchange ("Cannamerx") one of the first cannabis and hemp auction platforms to go live. The Company’s intention is to help Cannamerx finance their business model and build their global footprint of clientele.

Cannabis Mercantile Exchange ("Cannamerx"), is the first fully automated B2B international auction platform for wholesale cannabis, cannabis products, as well as hemp and hemp products, and genetics, to recommend certain products and services provided by each company to their respective customer base. There are more than 57 Canadian licensed cannabis companies that have joined Cannamerx, and since June 2018 it has helped facilitate the trade of more than 25 tonnes of cannabis, over $22 M in bids received through its automated auction platform as well as supply agreement auction process. (Cannamerx) ( https://www.cannamerx.com )

“Investing in a working cannabis auction platform in the sector is a game-changer. Cannamerx has the ability to connect European buyers with Canadian licensed sellers and South American licensed producers can with a click of a mouse list their products placing reserve prices to the rest of the world. There are many technology marketing plans to connect the world but Cannamerx have already established themselves as the go-to platform. Redfund recognizes that this is one of our most strategic growth alliances complementing our philosophy of funding entities that have realized revenues and are looking to grow exponentially. Redfund will release terms of the deal in the next week,” said Meris Kott, CEO, Redfund Capital Corp.

“We are very excited to be working with Redfund,” said Dietwald Claus, founder and CEO of Cannamerx, “Redfund’s resources and international network in the cannabis and hemp industry will accelerate our plans to position Cannamerx as the leading, international market place for cannabis and hemp. Redfund’s partnership with us is a further validation of our business model and strategy. We look forward to working with Redfund to develop our European market reach as a first step in this partnership.”

[tzadoz2014]

News

https://web.tmxmoney.com/article.php?newsid=6144232721563013…

VANCOUVER, British Columbia, March 21, 2019 (GLOBE NEWSWIRE) -- Redfund Capital Corp. (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) (“Redfund” or the “Company”) announces the launch of the Cannabis Mercantile Exchange ("Cannamerx") International Hemp/CBD Auction Platform.

Yesterday, Cannamerx launched the first international global Hemp/CBD auction platform. Building on the success of their existing cannabis trading platform, today they reported 1.5 tonnes of hemp biomass have been listed for auction on their site. Cannamerx is currently and rapidly onboarding hemp clients in Canada, the United States and Europe and is in the process of vetting CBD labs in the United States for trade within the USA. The management team will be attending the International Cannabis Business Conference (ICBC) Berlin March 31-April 2 and will be presenting their platform to the European industry. (www.cannamerx.com)

“The Global Hemp industry saw $3.7 billion in sales in 2018. That represents a 350 percent increase from 2017’s total of $820 million. China was the largest seller of hemp in 2018, accounting for about one-third of all global sales ($1.2 billion). The U.S. was second with $1 billion in sales, followed by Europe at $980 million and South & Central America at $220 million. New Frontier Data attributes the growth primarily to Chinese textiles, European industrials, Canadian foods, and the U.S. hemp-derived CBD market. According to the report, the global hemp market will reach $5.7 billion by 2020.” (www.benzinga.com)

“The hemp revolution has begun in North America. We are excited to help Cannamerx create a global path for many of these companies to trade Hemp/CBD internationally and become cash flow positive at a much quicker pace, decreasing their sales and marketing expenses and removing the “middleman” thereby increasing net revenues. By next fall, we are hopeful CBD edibles will be federally approved and licensed in Canada with Cannamerx’s platform providing the raw materials to licensed LPs, who need hemp,” stated Meris Kott, CEO, Redfund Capital Corp.

“We look forward to working with Redfund to roll out our platform and services for markets outside North America. We are excited that the market is validating our model so quickly. We feel we are truly redefining the way these products transact at the commodity level, and our move into international markets comes at the perfect time," said Dietwald Claus, founder and CEO of Cannamerx.

[tzadoz2014]

News - nächste Finanzierung

https://web.tmxmoney.com/article.php?newsid=5973062287068734…

VANCOUVER, British Columbia, March 28, 2019 (GLOBE NEWSWIRE) -- Redfund Capital Corp (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) (Redfund or the “Company”) is pleased to announce that it has signed a promissory note with Cannaki Beverage Inc. (“Cannaki”)

The Company

Cannaki Beverage Company Inc. manufactures natural and organic functional beverages. Based in Las Vegas, USA, the Nevada company’s core products are still and carbonated beverages and Cannaki specializes in Nano CBD infused flavored waters. Their CBD is farm-direct and ISO certified and contains Zero THC. Cannaki also manufactures and sells other organic, kosher and vegan products. Their mission is to make great tasting beverages without sacrificing quality. To blend botanical nutrition with “KI” natural goodness. To create a world of beverages with integrity and transparency — with no limits on taste, quality, geography or imagination. Cannaki’s core values guide them in their quest. ( http://cannaki.com )

The Investment

Redfund and Cannaki signed a 2 year term convertible secured promissory note on March 27th 2019 for US$1,000,000 at an annual interest rate of 14%. The Note may be converted at Redfund’s discretion at any time during the term and the Company has a right of first refusal to provide financing to Cannaki upon the same business terms as are being offered to Cannaki by any other funders. Cannaki will afford Redfund stock warrants in its common stock equivalent to twenty percent (20%) of the amount of the Note based upon their current valuation as of the effective date which is stipulated to be US $20,000,000.

“Cannaki has a strong network in the USA, Mexico and Europe and they are planning to expand their products’ reach to Asia and South America. We hope to help Cannaki align with a licensed Canadian producer and place their products on shelves in Canada when CBD beverages are permitted in Canada. Welcoming a beverage company with a strong experienced team to the portfolio is very exciting for Redfund and our beverage division. We believe branded products in the cannabis sector with a global rollout strategy will continue to emerge and lead the industry.” stated Meris Kott, CEO of Redfund Capital.

[tzadoz2014]

Keine wirklich neuen Informationen. Eher eine Zusammenfassung. Wenn man das erreicht, was am Schluss gesagt wird (70 Mio. $ und 20 Clients), wäre hier eine Vervielfachung durchaus möglich. Aktuell habe ich aber meinen Zweifel. Da mir die Entwicklung seit meiner Thread-Erstellung (05.10.2018) viel zu langsam geht. Weshalb ich derzeit auch nicht mehr investiert bin. Was sich aber durchaus jederzeit wieder ändern könnte. Und was die Frau Kott über die Bewertungen bei Cannabis-Unternehmen sagt, da stimme ich mit ihr überein.

https://web.tmxmoney.com/article.php?newsid=7644056304428031…

Redfund’s goal for 2019 is to raise $70 million and welcome 14 more projects into its portfolio, growing it to an even 20 clients. Convincing the marketplace that these smaller companies have revenues in excess of $2 million to $4 million when some of the larger footprints in the public markets have valuations in the hundreds of millions, yet have less revenue than the small cap company, is seen as key to reaching that goal, Kott said.

“What’s puzzling to me and what’s going to be the biggest detour or biggest obstacle is that in the capital markets right now, people are funding companies that have less revenues as a whole than some of our startups we are working with,” she said. “So that fundamental difference is probably the only roadblock ahead of us.”

Kott said she believes 2019 will be a “big year” for Redfund as it looks to raise $70 million and continues to serve the $20 million in projects currently under its portfolio.

[tzadoz2014]

News:

https://web.tmxmoney.com/article.php?newsid=6426606235469256…
Redfund Capital Announces OTCQB Listing

https://web.tmxmoney.com/article.php?newsid=5102721149014035…
Redfund Capital Inks Cannamerx Financing

[tzadoz2014]

News

https://web.tmxmoney.com/article.php?newsid=5552251439847473…
Redfund Capital Corp Launches Dr. Klein CBD

[tzadoz2014]

Oh, die Firma lebt noch. Endlich mal was Neues. Allerdings reicht es noch lange nicht aus, damit ich hier wieder einsteige. Die Entwicklung seit meiner Threaderstellung im Oktober 2018 finde ich enttäuschend. Ich hatte deutlich größere und schnellere Fortschritte erwartet. Eine MCap von 5,6 Mio. einer Cannabis-Gesellschaft spricht ja Bände. Sollte allerdings hier mal "richtig" was passieren, ist aufgrund der aktuellen Bewertung der Hebel natürlich sehr groß. Eine Vervielfachung in kürzester Zeit wäre da möglich. Nur fehlt mir im Moment der Glauben dazu.

https://web.tmxmoney.com/article.php?newsid=5419084107963426…
VANCOUVER, British Columbia, June 24, 2019 (GLOBE NEWSWIRE) -- Redfund Capital Corp (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) (Redfund or the “Company”) is pleased to announce that it has signed a strategic business cooperation agreement with Fantasy Network Ltd. (TASE: FNTS) of Tel Aviv, Israel to joint venture medical cannabis projects.

Redfund Capital and Fantasy Network have entered into a strategic cooperation agreement to form the foundation to joint venture business opportunities in the Israeli medical cannabis sector. This agreement enables Redfund to have a partner in Israel to evaluate potential acquisition and financing of Medical Cannabis, CBD, and Hemp companies in the region. The signed agreement provides a framework for Redfund to be able to access projects currently controlled by Fantasy or under negotiation primarily in Israel. Redfund will also assist Fantasy to license patented Israeli medical technology and cannabis delivery systems outside of Israel, as well as provide capital alongside Fantasy to medical cannabis companies. The term of this agreement is for 3 years.

On June 5, 2019, Fantasy Network announced the appointment of Redfund Capital CEO Meris Kott as an investment advisor to their company. Ms. Kott recently met with management in Tel Aviv and reviewed Fantasy’s current medical Cannabis portfolio with the aim to begin immediately.

Globally known as the best in class, Israel has a plethora of cannabis researchers, farmers, and entrepreneurs all focused on medical cannabis. The Israeli government has given support to the industry since 1973 and with recent approval from the Israeli parliament to export Israeli products, the global market is now open for Israeli companies to expand worldwide.

“Israel is home to novel cannabis drug delivery devices, patented grow and planting technologies, holistic cannaceuticals and pharma-grade medical cannabis. The people and companies I was introduced to during my trip to Tel Aviv, assures me that Redfund’s partnership with Fantasy will be a lucrative relationship for both our stakeholders. Redfund is already in discussions to bring Israel medical cannabis based companies global with Israeli licensing agreements with Canadian Licenced Producers and distribution contracts in other countries where medical cannabis is legalized,” stated Meris Kott, CEO.

[tzadoz2014]

Viel Neues gab es zuletzt nicht. Die Homepage ist eher weiterhin dürftig.
Einzig interessant finde ich aktuell das Thema "Wahupta". Allerdings weiß ich nicht, wie da der Stand ist. Besitzt man da Anteile dran. Oder hat man das recht welche zu erhalten. Oder ist es nur eine Kooperation.
Hatte schon bereits deshalb per Email nachgefragt. Aber keine Antwort erhalten.

[tzadoz2014]

Redfund ist ja mal damit angetreten, eine Art Bank oder Finanzierungsalternative für Cannabisfirmen zu sein und werden. Seit längeren kommt von denen überhaupt nichts mehr.
Und jetzt kommt noch Banking Bill dazu https://www.marijuanamoment.net/house-approves-marijuana-ban…
Ich könnte mir vorstellen, dass damit eine erfolgreiche Entwicklung dieser Firma sich nochmals erschwert hat.

[tzadoz2014]

News

Die Firma lebt noch. Es kommt tatsächlich mal was von denen. Allerdings nichts, was direkt für einen Kursanstieg sorgen könnte. "Nur" eine neue Person.

https://www.stockwatch.com/News/Item.aspx?bid=Z-C%3aLOAN-281…
Ms. Meris Kott reports

INTERNATIONAL BRANDING EXECUTIVE ASHLEIGH VOGSTAD JOINING REDFUND CAPITAL; MILLENNIAL MARKETEER BOLSTERS BOARD OF DIRECTORS

Redfund Capital Corp. has appointed Ashleigh Vogstad, an international marketing and branding trailblazer, to the board of directors of the company.

Ms. Vogstad is the founder and chief executive officer of Transcends, a marketing agency that excels in branding and facilitates partnerships for technology companies and their global vendors like Microsoft. Her previous roles have included being president for a $100-million FMCG company in the United States, owner of a Canadian hospitality concept, partner in a VC firm investing in biotech and sitting on several charitable boards, including running marketing and crisis management for his holiness, the Dalai Lama, during his Canadian tour.

"We could not be more fortunate to bring an amazing woman and millennial to the board. Ashleigh commutes between Seattle and Auckland and her international reach is something that will enhance all our new projects. Branding our own health and wellness products and those of our portfolio clients will be a win-win for everyone," stated Meris Kott, chief executive officer. "It is rare to have three women on a public company board and it is a hope of mine that more companies follow our lead."

[tzadoz2014]

Sie leben noch. Mal sehen, ob daraus etwas verbindliches wird. Oder ob sich der Deal im Sande verläuft.

https://www.stockwatch.com/News/Item?bid=Z-C%3aLOAN-2835116&…

Redfund Capital Corp. has signed a letter of intent to acquire the Sunshine State Tea Company (SSTC), based in Florida, United States.

The letter of intent was signed on November 7th 2019 and will be effective for a period of sixty days or until a definitive agreement is signed between the parties. Redfund agrees to purchase 100% of SSTC which would include all formulas, rights, licenses, and concessions of SSTC obtained either before or after the effective date of the agreement. The Company will commit to at least CDN $500,000 of funding towards the project over a 3 year period, and raise additional funds to support SSTC products expansion. Redfund will agree to a purchase price with consideration in common shares, and the valuation and amount of shares shall be agreed upon between Redfund and the Sunshine State Tea Company after completion of the due diligence process and applicable regulatory approvals.

The US government legalized cannabinoid with a maximum of 0.3% of THC under the Farm Bill Act in December 2018. In the journal Neurotherapeutics in 2015 they derived that CBD, a non- psychoactive compound, can actually help reduce anxiety in people with certain anxiety-related behavioral disorders, treating stress, anxiety, depression, and insomnia. Zenith Global guestimates that the US CBD-filled market will reach an estimated USD 1.4 billion by 2023, making it one of the fastest growing sectors in the overall industry.

"According to the Tea Association of America, tea is still the most consumed beverage in the US next to water. Upon the signing of a definitive agreement, Redfund will have a path to its first direct revenue stream in this globally evolving CBD-infused beverage market. We will continue to expand our reach into profitable revenue streams as the CBD market expands and is given more exposure promoting its health and wellness benefits." said Meris Kott, CEO, "We are hoping to sign the definitive in the next few weeks and look forward to pushing this CBD tea brand forward," added Meris Kott.

The Company further wishes to announce that it has granted 100,000 options to a Director. The options were issued pursuant to Redfund's stock option plan and shall be exercisable into common shares for a period of five years being November 19, 2024 at a price of $0.17.

[tzadoz2014]

News am 04.12.2019

https://www.stockwatch.com/News/Item?bid=Z-C%3aLOAN-2842800&…
REDFUND BEVERAGE DIVISION ADVANCES RELATIONSHIP WITH PORTFOLIO CLIENT

Redfund Capital Corp. has signed a promissory note with its portfolio client, White Barrel Wines Inc. (WBW).

The strategy

WBW has the ability and a history of formulating beverages and can respond very quickly to market demand, and develop and introduce new products in a competitive way. This would include coffees, cocktails, even water in a canned format, as well as cannabidiol-infused beverages in aluminum cans.

"Expanding our beverage division this quarter is quickly coming to fruition. The management at White Barrel Wines impressed me with their forward-looking thinking and execution; already with global purchase orders on hand. As the Canadian sector welcomes beverages with Cannabis 2.0, globally, the surge for new beverages not in a bottle has already commenced. Companies from outside the sector, such as White Barrel, will help advance mainstream CBD and wellness beverages," commented Meris Kott, chief executive officer.

The company

White Barrels Wine was established by a group of Vancouver entrepreneurs. The company's goal is to provide high-quality wines at budget prices not only to Canadian consumers, but to a worldwide marketplace. To facilitate that, the company is establishing its production facility in the Western Cape of South Africa, where it can ship excellent wines at budget-friendly prices as well as ship direct to worldwide markets from the Port of Cape Town. Foreseeing the need for packaging that is less expensive, easier to recycle and more convenient to the consumer than glass, the company elected to package all of its products in recyclable aluminum cans.

The investment

Redfund and WBW signed a two-year convertible secured promissory note on Nov. 28, 2019, for $500,000 at an annual interest rate of 10 per cent. The note may be converted, at Redfund's discretion, at any time during the term, and the company has a right of first refusal to provide financing to WBW upon the same business terms as are being offered to WBW by any other financiers. WBW afforded Redfund stock warrants in its common stock equivalent to 20 per cent of the amount of the note, based upon the current valuation as of the effective date, which is stipulated to be $2-million. The loan is collateralized under a general security agreement by the assets of White Barrel Wines.

[tzadoz2014]

Neue Beteiligung
Mal sehen, ob Redfund irgendwann mal wieder interessant wird. Ich bleibe auch nach dieser Meldung nur an der Seitenlinie. Immerhin ist es aktuell ein "guter" Zeitpunkt, um Firmen aus der Cannabisbranche zu übernehmen oder sich an denen zu beteiligen. Da mittlerweile (wohl) nicht mehr diese lächerlichen Mondpreise gezahlt werden.

https://www.stockwatch.com/News/Item?bid=Z-C%3aLOAN-2864188&…
Redfund Capital Corp. has signed the definitive agreement for an equity stake in the Sunshine State Tea Company (SSTC), based in Florida, United States.
The company has agreed to purchase 18 per cent of SSTC with consideration in common shares and has agreed to the valuation of Sunshine State Tea being $1.5-million.

[FranklinOpen]

Antwort auf Beitrag Nr.: 62.658.736 von tzadoz2014 am 12.02.20 15:59:08

Schön zu lesen dass Redfund noch aktiv ist.

Danke dir, tzadoz, dass du hier hin- und wieder noch postest.

Ich bin hier seit dem Cannabis-Hype mit einer kleinen Position investiert, weil mir das Geschäftsmodell mit den Unternehmensbeteiligungen eigentlich ganz gut gefällt. Leider ist die Blase dann geplatzt und jetzt dümpeln alle Cannabis-Werte mit -90% dahin. Hier hilft nur ein langer Atem. Ich werde auf jeden Fall drin bleiben und die Chance wahren, dass einer von Redfunds Partnern vielleicht doch noch irgendwann mit einem guten IPO groß rauskommt.

[tzadoz2014]

Antwort auf Beitrag Nr.: 62.868.453 von FranklinOpen am 03.03.20 18:26:13

Der letzte, am 02.03.2020 veröffentlichte Finanzbericht, war natürlich weiterhin wieder sehr bescheiden. Solange keine der Firmen an die Börse geht, solange wird sich bei Redfund wohl auch nichts tun. Dazu sind die Anteile und die teils erzielten Zinseinnahmen zu gering, um wirklich für Interesse zu sorgen. Aufgrund der niedrigen MCap kann man aber natürlich spekulativ hier investieren. Mit dem Wissen, dass es aktuell ein Zock ist und (meiner Meinung nach) schlimmstenfalls auch ein Totalverlust droht.

Das Geschäftsmodell finde ich weiterhin durchaus interessant. Nur geht es mir derzeit hier viel zu langsam voran. Was natürlich mit Sicherheit auch am massiven Einbruch des gesamten Sektors liegt.

[tzadoz2014]

Redfund steigt jetzt auch "indirekt" in das Anti-Corona-Geschäft ein.
Macht aus Sinn, da auch das Cannabisgeschäft unter der steigenden Arbeitslosigkeit und den Ausgangssperren in Übersee leiden dürfte.

https://www.stockwatch.com/News/Item?bid=Z-C%3aLOAN-2883072&…
2020-03-26 09:20 ET - News Release

Ms. Meris Kott reports

REDFUND CAPITAL AND SUNSHINE STATE TEA LAUNCH JOINT-DEFENSE TO VIRUS PANDEMIC AMERICAN-MADE HAND SANITIZER DEFENDS COVID-19

Redfund Capital Corp. has urgently joined forces with its portfolio client, Sunshine State Tea, based in Florida, in collaboration with Intercontinental Hemp of Washington State to immediately manufacture a line of hand sanitizer products to help combat COVID-19.

The hand sanitizer products are already in production in Washington State as part of premium personal care brand Sunshine State; wholesale purchase orders are being vetted by the team. A consumer website will launch for Sunshine State Tea next week to meet individuals' increased demand during the pandemic. The sanitizer is being offered in 1-litre/34-ounce and 500-millilitre/17-ounce sizes with push pump and 119-millilitre/four-ounce and 60-millilitre/two-ounce sizes with flip caps.

Sunshine State uses locally sourced ingredients that are safe for use on ones body. The active ingredient in the hand sanitizer is ethyl alcohol 70 per cent. The inactive ingredients are aloe vera juice, carbomer, glycerine, propylene glycol, triethanolamine and tocopheryl acetate. Sunshine State will ship both domestically and internationally. It is its social responsibility to look after its health and the health of its communities globally, as well as in its own countries of the United States and Canada.

When the World Health Organization declared the coronavirus a worldwide pandemic, defined as the worldwide spread of a new disease, the company knew it had the networks and abilities to make a global difference. The spread of the coronavirus globally fuelled the increased demand for sanitizer products and the company is glad to be part of the team helping wipe out COVID-19.

The CDC, on March 14, 2020, stated: "Hand washing mechanically removes pathogens, while laboratory data demonstrate that 60 per cent ethanol and 70 per cent isopropanol, the active ingredients in CDC-recommended alcohol-based hand sanitizers, inactivates viruses that are genetically related to, and with similar physical properties as, the 2019-nCoV."

"I am very proud that as the capital markets react to uncertainty, members of the Redfund team focused and assembled for an outreach program that relies on global empathy, co-operation and community building that sit at the heart of every international movement. Redfund director Ashleigh Vogstad stepped up and created an international initiative for the company, making certain we created a robust hand sanitizer business-to-business program to help stop the transmission of the virus by manufacturing essential products for the public. The company is excited to use her platform and support all of us defend ourselves against COVID-19. Be safe," said Meris Kott, chief executive officer Redfund.

[tzadoz2014]

News

Ich bin ja mal gespannt, ob die Firma mal so richtig zum Leben erwacht. Also eine der Beteiligungen an die Börse geht. Oder man auf eine andere Weise wesentliche Erlöse erzielt. Man zum Beispiel die Mehrheit an einer der Beteiligungen besitzt und diese vollkonsolidiert.

https://www.stockwatch.com/News/Item?bid=Z-C%3aLOAN-2907290&…
Redfund Capital Corp. has granted an aggregate of 1.44 million options to purchase common stock to certain directors, officers and consultants. The options are exercisable at a price of eight cents per share and will expire in five years. All options were granted in accordance with Redfund's stock option plan as approved by the shareholders in August, 2019.

Meris Kott, chief executive officer, said: "As we continue to monitor the progress and success of our clients' companies, we have begun to focus our energy to expand the company's portfolio and offerings with an emphasis on global wellness. We are excited to introduce these initiatives to our shareholders over the coming weeks."

[tzadoz2014]

Zudem gab es am 24.04.2020 Neuigkeiten zu Sunshine State Tea LLC

https://webfiles.thecse.com/sedar_filings/00011372/200423112…

[tzadoz2014]

Es scheint mir so, als will Redfund weg vom bisherigen Geschäft der Beteiligungsgesellschaft. Und stattdessen mehr ins aktive Geschäft einsteigen. Also direkt über Mehrheitsbeteiligungen Umsätze generieren.

https://www.stockwatch.com/News/Item?bid=Z-C%3aLOAN-2909330&…

Redfund Capital Corp. has launched its new website, adding a new focus on global wellness. The company is also very fortunate to welcome Leah Kincaid of Intercontinental Hemp LLC as a new United States brand adviser to its Redfund team.

Redfund's core mandate continues to be to empower global wellness worldwide as an incubator and accelerator to companies that focus on preventative health, wellness issues and related consumer products in the hemp and cannabidiol (CBD) sectors. Redfund provides financial, operational and management assistance to various companies in which it has lent capital or taken an equity position. Working together with its clients, the company helps them implement dynamic strategies that also includes brand development, assistance to build the right team and quickly move to accelerated revenue generation.

The Redfund team is dedicated to the optimum for its planet's citizens and in finding solutions to today's most pressing issues. The company brings together leaders and innovators from the medical, science, business, technology, research and media workplaces.

Ms. Kincaid is the visionary founder and chief executive officer of Intercontinental Hemp in Seattle, Wash. In the past six years, Ms. Kincaid has brought together an exceptional transnational team to execute her vision for the full potential of hemp as a product for health and well-being worldwide. Leveraging her 25-plus years of finance, banking, management and sales experience, she has knit together a cohesive plan in a new and fragmented industry and also built successful white label production plants. Her hope is to help the world have a better understanding of the uses and benefits of hemp, along with the benefits to the environment and a healthy mind, body and soul.

Meris Kott, chief executive officer, said: "The company has graduated to the next stage in our growth process. In the coming months, we will decide which original loans to convert into equity of our investments and which to be repaid. Additionally, which clients in the pipeline the company will finance and bring to the next level. In these unprecedented times, those clients who have made successful social pivots are impressive. Felicidades to the team at Biominerales Pharma who decided to remain in Colombia and did not furlough any employees and developed a Colombian-based sanitizer brand to help fight COVID-19. To our shareholders, keep safe and look for an increase on news flow via our website. Please sign up on-line so we can keep you informed."

Company options update

The company further announces that it has granted an aggregate of 150,000 options to purchase common stock to an officer of the corporation. The options are exercisable at a price of eight cents per share and will expire in five years. All options were granted in accordance with Refund's stock option plan as approved by the shareholders in August, 2019.

[tzadoz2014]

Mal wieder eine Meldung. Aber auch mal wieder nichts weltbewegendes.

https://www.stockwatch.com/News/Item?bid=Z-C%3aLOAN-2924672&…
SUNSHINE STATE TEA BEGINS ROLL OUT OF CBD & VITAMIN INFUSED TEAS

[tzadoz2014]

News

Bringt dies endlich mal Einnahmen/Erlöse ?
Da all die bisherigen Beteiligungen ja nicht viel gebracht haben. Bislang kein IPO von denen. Und auch kein lukrativer Verkauf der Anteile.

https://www.stockwatch.com/News/Item?bid=Z-C%3aLOAN-2937188&…

Redfund Capital Corp. has signed a distribution agreement with Hempfy Switzerland to market and distribute Hempfy's products in North America, New Zealand and Australia.

Redfund Capital and Tellement Facile SA (under the trade name Hempfy) have signed a distribution agreement for the North American markets of Canada and United States plus New Zealand and Australia. The term is to be two years and to be automatically renewed for successive two two-year terms thereafter.

Hempfy products are 100 per cent legal in most jurisdictions with no THC (tetrahydrocannabinol) and no CBD (cannabidiol). Hempfy drinks have been specially developed for those who appreciate the unique taste of cannabis. The drink flavours Cannabis Bitter Lime and Cannabis Sweet Lime draw their unique taste from the hemp infusion. The new Hempfy natural chewing gum is chicle based, biodegradable, nature friendly, sugar-free, vegan friendly and non-GMO (genetically modified organism). Hempfy focuses on innovative foods and beverages based on proprietary cold infusion technology for harvesting and processing THC-free cannabis plants, compliant with Swiss legislation. All the products are 100 per cent Swiss made from growing hemp and producing and developing all products exclusively in Switzerland. Hempfy considers it the Swiss way of doing things.

Meris Kott, chief executive officer, commented: "This global wellness initiative began over two years ago in Geneva when we met the principals of Hempfy and we have continued following their tremendous organic growth. Seed-to-sale companies vertically integrated are very rare and Hempfy's success is due to the total commitment of their team to all details in producing their products. Our distribution channels currently developed at Redfund should enable Hempfy to be on new shelves first in North America very quickly. "

[tzadoz2014]

Hin und wieder bringt das Unternehmen mal eine Meldung raus. Nur hat sich am Kurs nichts geändert. Und das bleibt wohl auch so, bis mal eine der Beteiligungen an die Börse geht. Oder man eine Beteiligung gewinnbringend veräußert. Die Aktie ist weiterhin nur etwas für spekulative Anleger mit einem sehr langen Atem. Ich bin aktuell weiterhin nicht investiert.

https://www.stockwatch.com/News/Item?bid=Z-C:LOAN-2991307&sy…
REDFUND CLIENT CANNAFORUM ADVANCES TO FINAL 20 FOR DUTCH CANNABIS LICENSE BK CAPITAL JOINS TEAM AS CAPITAL MARKETS EXPERT

[tzadoz2014]

Aus Redfund Capital wurde jetzt Global Wellness Strategies Inc.
Ob sie jetzt auch endgültig ihre Strategie ändern, muss man abwarten. Und zukünftig eher als Holding agieren wollen. Zudem wurde die Anzahl der Aktien deutlich herabgesetzt, weshalb der Kurs optisch jetzt angestiegen ist.

https://www.stockwatch.com/News/Item?bid=Z-C:LOAN-3020241&sy…
Redfund Capital Corp. has changed its name to Global Wellness Strategies Inc. and consolidated its issued and outstanding common shares on the basis of one postconsolidated common share for every four preconsolidated common shares.
As a result, the outstanding shares of the company will be reduced to approximately 15,854,726 common shares.
The symbol will remain the same (LOAN).
The shares will begin trading on a consolidated basis and with a new Cusip number on Jan. 22, 2021.

https://www.stockwatch.com/News/Item?bid=Z-C:LOAN-3017653&sy…
"The name Global Wellness Strategies Inc. is highly aligned with our mission and positions us to capitalize on the growth in consumer demand for health and wellness products across all categories. We have made the decision to focus entirely on being a prospect generator for global wellness products and partnering with our clients' desires to work together to build a better world. Our board is committed to our shareholders and showing them their continued support is valued, and we plan on increasing our marketing awareness programs to promote our clients and the company brands," said Meris Kott, chief executive officer.

[tzadoz2014]

News

https://money.tmx.com/en/quote/LOAN:CNX/news/882778628148283…

Vancouver, British Columbia--(Newsfile Corp. - January 27, 2021) - Global Wellness Strategies Inc. (formerly Redfund Capital Corp.) (CSE: LOAN) (FSE: O3X4) (OTCQB: PNNRD) ("Global" or the "Company") announces it has signed a binding letter of intent ("BLOI") on January 22, 2021 with EntheoTech Bioscience Inc. ("ET") a wellness psilocybin leader based in Kelowna, British Columbia and will have the option to earn up to a 19.9% interest in ET.

EntheoTech is a Canadian bioscience company focused on the research and development of products, and protocols to promote brain health, performance optimization, and global wellness, using psychoactive substances such as psilocybin, medicinal mushrooms, and other natural products.

EntheoTech's initial focus will be the treatment of depression, anxiety and chronic pain using microdoses of natural psilocybin from proprietary genetics in a Health Canada approved clinical trail targeted for 2H 2021. EntheoTech will also be launching a direct-to-consumer line of functional mushroom products using unique formulations and manufacturing methods to increase bioavailability and efficacy.

The BLOI signed between the Company and ET sets out the parameters for the proposed transactions and the due diligence period will last 60 days consummating with the signing of a definitive agreement detailing the exact terms of the deal. Global agrees to purchase 19.9% of the rights to the products and licenses from ET at a valuation to be determined during the due diligence period. The Company proposes to sign a promissory note with ET up to CDN $2,500,000 and to additionally raise capital in specific fundings to support the continued development of ET projects. Global shall also have a right of first refusal to provide financing to ET upon the same business terms as are being offered to ET. Should ET be offered any additional loans, financings, stock offerings, debt offerings or capital contributions by third parties ("Offer"), Global shall be given written notice thereof and shall have forty (40) business days to exercise its right of first refusal to lend or contribute such sums on the same terms and conditions as contained in the offer.

[tzadoz2014]

Ich bin mal gespannt, ob sich hier nochmal irgendwann etwas tut. Man bringt zwar immer wieder mal Meldungen heraus. Aber die Finanzberichte bewegen mich weiterhin nicht, um hier wieder einzusteigen. Ob Sunshine State Tea mittlerweile Umsätze erzielt, ist mir nicht bekannt.

Letzte zwei Meldungen:
https://globalwellnessstrategies.com/2021/08/09/cannvalate-d…
Global Wellness Strategies Inc. (formerly Redfund Capital Corp.) (CSE: LOAN) (Frankfurt:O3X4) (OTCQB: PNNRF) (“Global” or the “Company”) is pleased to announce the signing of a definitive agreement on August 6th 2021 memorializing the Global Wellness Strategies, Inc. binding letter of intent signed on July 12th 2021 to purchase certain assets of Cannvalate Pty Ltd. (“CV”) based in Australia and to acquire 100% of their wholly owned subsidiary, Shanti Therapeutics Pty Ltd. (“Shanti”), and all its assets focused on psychedelic MDMA-based drug development. This acquisition is focused on becoming the first and only company solving the puzzle of chronic pain with MDMA-based medicines utilizing clinical trials for the purposes of novel drug development.

https://globalwellnessstrategies.com/2021/06/15/global-welln…
Global Wellness Strategies Inc. (CSE: LOAN) (FSE: O3X) (OTCQB: PNNRF) (formerly Redfund Capital Corp.) (“GWS” or the “Company”) is pleased to provide the following corporate update highlights on two portfolio clients KaleidoMyco LLC and Biominerales Pharma Corp. and announces the signing of the one-stop digital marketing team of North Equities Corp.

[tzadoz2014]

Global Wellness (ehemals Redfund) hat am 30.08.2021 mal wieder Finanzzahlen vorgelegt. Bislang hat sich noch nicht viel getan. Nichts auffälliges bei den Umsätzen oder der Bewertung der Beteiligungen in den Büchern. Gemacht haben sie ja zuletzt einiges. Ob auch etwas zählbares da mal herausspringt, muss man sehen.

[tzadoz2014]

Kursverlauf enttäuschend. MCap dementsprechend mittlerweile auch recht niedrig. Und immer wieder neue Geschäftsideen und neue Beteiligungen und Übernahmen. Ich bin derzeit nicht investiert. Wenn man hier einsteigen möchte, wäre dies nur etwas für hoch spekulative Anleger etwas.
News gibt es ja genug. Aber alleine nur Meldungen raushauen reicht nicht. Es muss irgendwann auch mal etwas dabei rumkommen. https://stockhouse.com/companies/news?symbol=c.gws

Aktuelles Portfolio: https://globalwellnessstrategies.com/portfolio-gws-wellness/

[tzadoz2014]

Am 02. Februar 2022 wurden mal wieder Finanzberichte auf sedar.com veröffentlicht. Ansonsten ist da nicht viel zu sagen. Weiterhin nur was für Zocker, die mit der Hoffnung hier einsteigen, dass die gefühlte hunderste Übernahme mal zum Erfolg wird.